Aquestive Therapeutics (AQST) Net Cash Flow (2017 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Net Cash Flow of -$10.4 million for Q1 2026, down 261.2% year-over-year from $6.5 million in Q1 2025, and down 32.19% quarter-over-quarter from -$7.9 million in Q4 2025.
Aquestive Therapeutics (AQST) Net Cash Flow (2017 - 2026) Analysis & Trends
Aquestive Therapeutics' Net Cash Flow history runs 10 years deep, the most recent figure standing at -$10.4 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 261.2% year-over-year to -$10.4 million; the TTM figure through Mar 2026 stood at $42.1 million (up 258.52% YoY), while the FY2025 annual figure was $49.6 million, up 4.09% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$10.4 million, down from -$7.9 million in the prior quarter.
- The five-year high for Net Cash Flow was $71.3 million in Q1 2024, with the low at -$13.3 million in Q1 2022.
- The 5-year median for Net Cash Flow is -$2.9 million (2025), against an average of $4.9 million.
- Peak annual rise in Net Cash Flow reached 18342.46% in 2024, while the deepest fall reached 582.75% in 2024.
- Aquestive Therapeutics' Net Cash Flow stood at $8.6 million in 2022, then plunged by 112.12% to -$1.0 million in 2023, then sank by 507.37% to -$6.3 million in 2024, then declined by 24.37% to -$7.9 million in 2025, then plunged by 32.19% to -$10.4 million in 2026.
- Business Quant data shows AQST's Net Cash Flow at -$10.4 million in Q1 2026, -$7.9 million in Q4 2025, and $68.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Aquestive Therapeutics | 560.60 Mn | 560.60 Mn | 9.80 Mn | -12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.24 Mn |
| Jun 30, 2026 | -12.24 Mn |
| Mar 31, 2026 | -10.44 Mn |
| Mar 31, 2026 | -10.44 Mn |
| Dec 31, 2025 | -7.89 Mn |
| Dec 31, 2025 | -7.89 Mn |
| Sep 30, 2025 | 68.53 Mn |
| Sep 30, 2025 | 68.53 Mn |
| Jun 30, 2025 | -8.12 Mn |
| Jun 30, 2025 | -8.12 Mn |
| Mar 31, 2025 | -2.89 Mn |
| Mar 31, 2025 | -2.89 Mn |
| Dec 31, 2024 | -6.35 Mn |
| Dec 31, 2024 | -6.35 Mn |
| Sep 30, 2024 | -11.98 Mn |
| Sep 30, 2024 | -11.98 Mn |
| Jun 30, 2024 | -5.33 Mn |
| Jun 30, 2024 | -5.33 Mn |
| Mar 31, 2024 | 71.33 Mn |
| Mar 31, 2024 | 71.33 Mn |